SLC5A2 and familial pancreatic carcinoma: Furthermore, data from the Cancer Genome Atlas showed that high SGLT2 expression coexisted with impaired cellular replicative surveillance, enhanced cellular metabolism and drug metabolism, and that high levels of SGLT2 coexisted with up-regulation of gene signatures in pancreatic progenitor cell subsets in pancreatic cancer (38).